<!DOCTYPE html>
<html>
<head>
  <!-- Site made with Mobirise Website Builder v3.11.1, https://mobirise.com -->
  <meta charset="UTF-8">
  <meta http-equiv="X-UA-Compatible" content="IE=edge">
  <meta name="generator" content="Mobirise v3.11.1, mobirise.com">
  <meta name="viewport" content="width=device-width, initial-scale=1">
  <link rel="shortcut icon" href="assets/images/logo.png" type="image/x-icon">
  <meta name="description" content="Website Builder Description">
  <title>Website Builder Title</title>
  <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Lora:400,700,400italic,700italic&amp;subset=latin">
  <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Montserrat:400,700">
  <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Raleway:100,100i,200,200i,300,300i,400,400i,500,500i,600,600i,700,700i,800,800i,900,900i">
  <link rel="stylesheet" href="assets/bootstrap-material-design-font/css/material.css">
  <link rel="stylesheet" href="assets/tether/tether.min.css">
  <link rel="stylesheet" href="assets/bootstrap/css/bootstrap.min.css">
  <link rel="stylesheet" href="assets/soundcloud-plugin/style.css">
  <link rel="stylesheet" href="assets/dropdown/css/style.css">
  <link rel="stylesheet" href="assets/animate.css/animate.min.css">
  <link rel="stylesheet" href="assets/theme/css/style.css">
  <link rel="stylesheet" href="assets/mobirise/css/mbr-additional.css" type="text/css">
  
  
  
</head>
<body>
<section id="menu-3y">

    <nav class="navbar navbar-dropdown bg-color transparent">
        <div class="container">

            <div class="mbr-table">
                
                <div class="mbr-table-cell">

                    <button class="navbar-toggler pull-xs-right hidden-md-up" type="button" data-toggle="collapse" data-target="#exCollapsingNavbar">
                        <div class="hamburger-icon"></div>
                    </button>

                    <ul class="nav-dropdown collapse pull-xs-right nav navbar-nav navbar-toggleable-sm" id="exCollapsingNavbar"><li class="nav-item"><a class="nav-link link" href="index.html">HOME&nbsp;</a></li><li class="nav-item"><a class="nav-link link" href="Introduction.html">OVERVIEW&nbsp;</a></li><li class="nav-item"><a class="nav-link link" href="Programme.html">PROGRAMME&nbsp;</a></li></ul>
                    <button hidden="" class="navbar-toggler navbar-close" type="button" data-toggle="collapse" data-target="#exCollapsingNavbar">
                        <div class="close-icon"></div>
                    </button>

                </div>
            </div>

        </div>
    </nav>

</section>

<section class="engine"><a rel="external" href="https://mobirise.com">Web Builder</a></section><section class="mbr-section article mbr-section__container mbr-after-navbar" id="content1-3z" style="background-color: rgb(255, 255, 255); padding-top: 120px; padding-bottom: 0px;">

    <div class="container">
        <div class="row">
            <div class="col-xs-12 lead"><p><strong>The anti-inflammatory role of Nrf2 activation</strong></p><p><strong><br></strong></p><p>Albena T. Dinkova-Kostova</p><p><br></p><p>Division of Cellular Medicine, University of Dundee School of Medicine, United Kingdom</p><p><strong>Email:&nbsp;</strong>a.dinkovakostova@dundee.ac.uk</p><p><strong><br></strong></p><p>Transcription factor Nrf2 and its main negative regulator Keap1 are at the interface of redox and intermediary metabolism. Nrf2 activation by small molecules that target Keap1 (termed inducers) provides protection via the transcriptional regulation of large networks of cytoprotective proteins. Additionally, pharmacologic Nrf2 activation linearly correlates with inhibition of pro-inflammatory responses. Studies in cellular and mouse models, as well as in human subjects consistently show the anti-inflammatory role of Nrf2 activation, although the underlying mechanisms are complex and incompletely understood. Recent high-resolution quantitative proteomics coupled with metabolomic analyses of bone marrow-derived macrophage (BMDM) cells from wild-type-, Nrf2-knockout and Keap1-knockdown mice showed that Nrf2 disruption significantly affected the proteome and metabolome of unstimulated and lipopolysaccharide (LPS)-stimulated BMDM cells, with alterations in redox, carbohydrate and lipid metabolism, and innate immunity. Interestingly, LPS stimulation caused a switch in mitochondrial morphology, from tubular to fused, which was enhanced by Keap1 knockdown and suppressed by Nrf2 disruption. The Nrf2 activator, 4-octyl itaconate (4-OI) remodelled the inflammatory macrophage proteome, increasing redox and suppressing the type I interferon (IFN) response in Nrf2-dependent manner. Similarly, pharmacologic or genetic Nrf2 activation inhibited transcription of IFN-β and its downstream effector IFIT2 during LPS stimulation. Overall, these data suggest that Nrf2 activation facilitates metabolic reprogramming and mitochondrial adaptation, and finetunes the innate immune response in macrophages.&nbsp;</p><p><br></p></div>
        </div>
    </div>

</section>

<section class="mbr-section" id="msg-box5-40" style="background-color: rgb(255, 255, 255); padding-top: 0px; padding-bottom: 0px;">

    
    <div class="container">
        <div class="row">
            <div class="mbr-table-md-up">

              <div class="mbr-table-cell mbr-right-padding-md-up mbr-valign-top col-md-7 image-size" style="width: 27%;">
                  <div class="mbr-figure"><img src="assets/images/albena-1400x1751.jpg"></div>
              </div>

              


              <div class="mbr-table-cell col-md-5 text-xs-center text-md-left content-size">
                  
                  <div class="lead">

                    <p><strong> Albena Dinkova-Kostova </strong>is Professor of Chemical Biology at the University of Dundee School of Medicine. She graduated in Biochemistry and Microbiology from Sofia University (Bulgaria) and obtained her PhD degree in Biochemistry and Biophysics from Washington State University (USA). She subsequently trained in Pharmacology at Johns Hopkins University School of Medicine (USA), where she continues to hold an Adjunct Professor position. She joined the University of Dundee in 2007 as a Research Councils UK Academic Fellow. In her research, at the interface of Chemical Biology and Medicine, she is committed to understanding the role of Keap1 and Nrf2 in mediating the cellular and organismal responses to oxidative, inflammatory, and metabolic stress, and is working towards development of pharmacological Nrf2 activators for protection against chronic disease. She was named among the top influential academics in Clarivate’s Highly Cited Researchers 2019, 2020, and 2021 lists.  </p>

                  </div>

                  
              </div>


              

            </div>
        </div>
    </div>

</section>


  <script src="assets/web/assets/jquery/jquery.min.js"></script>
  <script src="assets/tether/tether.min.js"></script>
  <script src="assets/bootstrap/js/bootstrap.min.js"></script>
  <script src="assets/smooth-scroll/SmoothScroll.js"></script>
  <script src="assets/dropdown/js/script.min.js"></script>
  <script src="assets/touchSwipe/jquery.touchSwipe.min.js"></script>
  <script src="assets/viewportChecker/jquery.viewportchecker.js"></script>
  <script src="assets/theme/js/script.js"></script>
  
  
  <input name="animation" type="hidden">
  </body>
</html>